UNSPSC 51391717: Ephedrine

This classification denotes an adrenergic agent with the molecular formula C10H15NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GN83C131XS, chemically known as 1s,2s-(+)-pseudoephedrine hydrochloride but generally known as ephedrine, which bears US NIH Compound Identifier 5032. European Medicines Agency schedules Ephedrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13683MIG. World Health Organization schedules ephedrine in its Anatomical Therapeutic Chemical (ATC) Classification.

Most nations schedule ephedrine under HS 29394100 and SITC 54144. As of Q4 2014, EPHEDRINE remains the US FDA Preferred Term for this commodity. Ephedrine bears US NLM identifiers UMLS ID C0014479 and NCI Concept Code C472. SMILES: CC(C(C1=CC=CC=C1)O)NC.

UNSPSC 51391717 Ephedrine is a Commodity code that in recent state and local procurement shows minimal direct activity tied to the ephedrine classification itself. The single concrete opportunity posted under this code—Seminole County, Florida's IFB60459723LAS issued June 30, 2026—actually solicits naloxone and safe drug deactivation systems rather than ephedrine products, with annual purchases of 1,900 units of naloxone and 800 deactivation systems through quarterly deliveries. A second record, the Texas Health and Human Services Commission's RFI HHS0017013 posted April 3, 2026, addresses direct-to-manufacturer prescription programs and pharmaceutical contracting models but does not specify ephedrine or any particular drug product. The code appears to see limited activity in state and local procurement, with issuing bodies including county health departments and state health and human services agencies, but the recent opportunities show a mismatch between the code's nominal scope and the actual products being solicited.

Seminole County, Florida represents the only recent state-local solicitation with concrete product specifications under this code. The naloxone and drug deactivation procurement requires electronic bidding through the county's e-procurement portal, carries an initial two-year term with one-year renewal option, includes potential FEMA funding, and mandates E-Verify compliance, drug-free workplace certification, and workers' compensation and liability insurance. The Texas RFI signals interest in direct pharmaceutical contracting but does not target ephedrine specifically, leaving the code with no clear geographic concentration or repeat-buyer pattern. Given the sparse and tangential recent activity, firms should treat this code as dormant in active state and local procurement unless the source material is supplemented with opportunities more directly tied to ephedrine products or controlled pharmaceutical substance procurement.